Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 2 |
2004 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.
J Clin Pharm Ther. 2003 Feb;28(1):53-9. doi: 10.1046/j.1365-2710.2003.00463.x.
J Clin Pharm Ther. 2003.
PMID: 12605619
Clinical Trial.
CONCLUSIONS: The results of this study indicate the efficacy of S. officinalis extract in the management of mild to moderate Alzheimer's disease. Moreover, S. officinalis may well reduce agitation of patients but this needs to be confirmed....
CONCLUSIONS: The results of this study indicate the efficacy of S. officinalis extract in the management of mild to moderate Alzheime …
Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial.
Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M.
Akhondzadeh S, et al.
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):863-6. doi: 10.1136/jnnp.74.7.863.
J Neurol Neurosurg Psychiatry. 2003.
PMID: 12810768
Free PMC article.
Clinical Trial.
METHODS: Patients with mild to moderate Alzheimer's disease aged between 65 and 80 years (n = 42; 18 women, 24 men) with a score of >or= 12 on the cognitive subscale of Alzheimer's disease assessment scale (ADAS-cog) and <or= 2 on the clinical dementia rating …
METHODS: Patients with mild to moderate Alzheimer's disease aged between 65 and 80 years (n = 42; 18 women, 24 men) with a score of & …
Item in Clipboard
Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S.
Mohammadi MR, et al.
J Clin Pharm Ther. 2004 Apr;29(2):139-44. doi: 10.1111/j.1365-2710.2004.00545.x.
J Clin Pharm Ther. 2004.
PMID: 15068402
Clinical Trial.
Item in Clipboard
Cite
Cite